• A case of juvenile systemic sclerosis and congenital pulmonary airway malformation related mucinous adenocarcinoma of the lung: paraneoplastic syndrome or just a coincidence?
• A case of Myhre syndrome mimicking juvenile scleroderma
• A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
• A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma
• Acute limb ischemia in an adolescent with COVID-19 and systemic scleroderma: a case report
• Advanced keratoconus in a child with juvenile scleroderma
• An international survey of developing classification criteria for juvenile dermatomyositis-scleroderma overlap
• Antibodies to histone in the pediatric population: a retrospective chart review
• Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort
• Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives
• Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022
• Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis
• Can vitamin D be an adjuvant therapy for juvenile rheumatic diseases?
• Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity Scale
• Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 years prospective observation
• Cardiovascular involvement in pediatric systemic autoimmune diseases: the emerging role of noninvasive cardiovascular imaging
• CD8⁺ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease
• Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
• Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review
• Childhood rheumatic diseases: bites not only the joint, but also the heart
• Clinical applicability of infrared thermography in rheumatic diseases: A systematic review
• Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020-2022 Survey of the Pediatric Rheumatology Association of Japan
• Connective tissue nevus misdiagnosed as juvenile localized scleroderma
• Consensus-based recommendations for the management of juvenile systemic sclerosis
• Contemporary outcomes of primary total hip arthroplasty in patients with inflammatory arthritis
• Conventional Radiography and Ultrasound Imaging of Rheumatic Diseases Affecting the Pediatric Population
• Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study
• Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma
• Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort
• DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma
• Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience
• Effects of sense and functionality changes in the hands on activity and participation in patients with juvenile scleroderma
• Emerging therapeutics in the management of connective tissue disease. Part II: Dermatomyositis and scleroderma
• Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity
• Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases
• Familial localized scleroderma with paediatric onset: a review
• Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients
• Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort
• Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease
• High-dose immunoglobulin therapy for steroid-resistant myositis in juvenile localized scleroderma
• How Is Pulmonary Function Assessed in Patients With Juvenile Systemic Sclerosis? Do We Have a Good Clinical Standard?
• Imaging Features of the Juvenile Inflammatory Arthropathies
• Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders
• Interferons Dominate Damage and Activity in Juvenile Scleroderma
• Juvenile and adult-onset scleroderma: Different clinical phenotypes
• Juvenile diabetes and systemic sclerosis: just a coincidence?
• Juvenile localized scleroderma
• Juvenile localized scleroderma: A disease with significant morbidity
• Juvenile localized scleroderma: A single-centre experience from India
• Juvenile Localized Scleroderma: Updates and Differences from Adult-Onset Disease
• Juvenile Scleroderma
• Juvenile Scleroderma-What has Changed in the Meantime?
• Juvenile Scleroderma: A Referral Center Experience
• Juvenile sclerosing polycystic adenosis cytologically mimicking Warthin tumor
• Juvenile systemic sclerosis - observations of one clinical centre
• Juvenile Systemic Sclerosis: A Rare Phenomenon
• Linear morphea with overlying lichen sclerosus and calcinosis cutis associated with juvenile dermatomyositis
• Management of juvenile-onset systemic sclerosis with systemic immunosuppressive therapies: An evidence-based review
• Morphea in Childhood: An Update
• Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis
• Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-up
• New developments in juvenile systemic and localized scleroderma
• New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction
• Non-invasive imaging and clinical skin scores in juvenile localised scleroderma
• Non-invasive imaging and clinical skin scores in juvenile localized scleroderma
• Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review
• Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification
• Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history
• Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study
• Performance of the New 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in Children and Young Adults
• Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma
• Primary complement and antibody deficiencies in autoimmune rheumatologic diseases with juvenile onset: a prospective study at two centers
• Profile of new referrals to a single pediatric rheumatology center in Turkey
• Proposed response parameters for 12 months drug trial in Juvenile Systemic Sclerosis. Results of the Hamburg International Consensus Meetings
• Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings
• Pulmonary Nodules in Juvenile Systemic Sclerosis: A Case-Series from the National Registry for Childhood Onset Scleroderma (NRCOS)
• Rarities in rare: illuminating the microvascular and dermal status in juvenile localised scleroderma. A case series
• Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring
• Scleroderma in children
• Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis
• Scleroderma in children: an update
• Scrotal Calcinosis in Juvenile Systemic Sclerosis
• Significance of pentraxin-3 in patients with juvenile scleroderma
• Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases
• Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study
• Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
• Successful treatment of children with juvenile systemic sclerosis using mycophenolate mofetil after methylprednisolone pulse therapy: A 3-year follow-up
• Systematic Review of Health-Related Quality of Life Impact in Juvenile Localized Scleroderma
• Systemic sclerosis sine scleroderma in children
• Systemic therapy in juvenile localized scleroderma
• Systolic and Diastolic Cardiac Functions in Juvenile Spondyloarthropathies
• The frequency of pulmonary hypertension in patients with juvenile scleroderma
• Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study
• Treatment in Juvenile Scleroderma
• Treatment of Fissure Caries of Children with Severe Rheumatic Diseases with Difficulty in Opening the Mouth
• Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments
• Ultrasonography in Pediatric Rheumatology
• Ultrasonography, MRI and classic radiography of skin and MSK involvement in juvenile scleroderma
• Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma
• Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment